Signature Ajuokenya image

Nevirapine

Combinations ; See Below

Nevirapine Brands
Brand Name Manufacturer Name Distributor Drug Strength Packaging Formulation Formulation Strength Price
Nevir Emcure Pharmaceuticals Limited Saicare Enterprises Ltd. 200mg 60 Tablet per tablet KES 1,650.00
Nevir Emcure Pharmaceuticals Limited Saicare Enterprises Ltd. 50mg 100ml Suspension per 5ML KES 520.00
Nevimune Cipla Ltd. Surgipharm Ltd 200mg 60 Tablet per tablet KES 450.00
Nevimune Cipla Ltd. Surgipharm Ltd 50mg 100ml Suspension per 5ML KES 135.00
Nevivir Hetero Drugs Ltd Unisel Pharma (K) Ltd. 200mg 60 Tablet per tablet KES 460.00
Neviriv Cosmos Limited. Cosmos Limited 200mg 60 Tablet per tablet KES 400.00
Viramune Boehringer Ingelheim International Laborex Kenya Eurapharma Ltd 200mg 60 Tablet per tablet KES 2,609.00
Viramune Boehringer Ingelheim International Laborex Kenya Eurapharma Ltd 50mg 240ml Suspension per 5ML KES 1,812.00

Nevirapine More info
Mode Of Action

Non-nucleoside reverse transcriptase inhibitors (NNRTIs or NtRTIs) that inhibit viral reverse transcriptase and viral DNA synthesis

Drug Indication HIV (in combination with other ARVs); Very useful in prevention of vertical transmission of HIV in the late pregnancy.
Precautions It is rarely affected by the status of renal functions hence there may not be any need of changing the dosage in case of renal impairement unless the creatinine clearance is below 20mlL/minute; paradoxically probability of hepatoxicity. increases with the increase of CD4 counts, with more pronounced effect in women. Rifampicin reduces its plasma concentration. Known to cause serious dermatological reactions in children. The incidence for rash is reduced if introduced at a low dose and dose increased after 14 days.
Contra-Indications Severe hepatic disorders (with AST or ALT levels of more than 5 times of the normal levels).
Side Effects The most common side effects are rashes and body weakness. Others include: hypersensitivity reactions; serious fulminant hepatitis; Steven-Johnson syndrome; anaemia; granulocytopenia and arthralgia.
Dosage Adults: 200mg OD x 2/52 then 200mg BD. Children: 2 months to 7 years; 4mg/kg OD x 2/52 then 7mg/kg BD (max. 400mg/day). 8 to 16 yrs; 4mg/kg OD x 2/52 then 7mg/kg BD (max. 400mg/day)
Pregnancy Category Category B3
Pregnancy Category Description Drugs which have been taken by only a small number of pregnant women and women of child-bearing age with no any established rise in the frequency of malformations or other direct or indirect detrimental effects on the foetus having been noted. Studies in animals show evidence of an increased occurrence of foetal damage, the significance of which is uncertain in human
Drug Category DRUGS ACTING ON INFECTIONS
Drug Sub-Category Hiv Chemotherapy